查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949470

生命科學產品設計與開發服務市場－全球產業規模、佔有率、趨勢、機會及預測（按階段、應用、最終用途、地區和競爭格局分類，2021-2031年）

Life Science Product Design & Development Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Phase, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生命科學產品設計和開發服務市場預計將從 2025 年的 250.6 億美元成長到 2031 年的 416.1 億美元，複合年成長率為 8.82%。

這些服務涵蓋了構思、設計和檢驗醫療設備、藥品和生物技術創新所需的專業技術流程，以滿足臨床和商業應用的需求。成長的主要驅動力是醫療技術的日益複雜化以及製造商在控制營運成本的同時加快產品上市速度的迫切需求。因此，各組織越來越依賴擁有專業工程技術的外部合作夥伴，以降低內部研發帶來的財務風險。根據歐洲製藥工業協會聯合會 (EFPIA) 的數據，到 2024 年，以研發為基礎的製藥業將在歐洲的研發領域投入約 550 億歐元，這凸顯了巨額資本支出將推動對高效研發解決方案的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 250.6億美元
市場規模：2031年 416.1億美元
複合年成長率：2026-2031年 8.82%
成長最快的細分市場 生物儲存
最大的市場 亞太地區

然而，市場擴張面臨一個重大障礙：嚴格且往往不一致的全球法規環境。應對複雜的合規框架，例如不斷變化的歐盟醫療設備法規和嚴格的FDA標準，需要投入大量資源，並導致漫長的檢驗週期。這種監管摩擦提高了准入門檻，可能延緩新產品的商業化進程，並給研發服務供應商及其客戶帶來壓力。

市場促進因素

隨著企業適應不斷上漲的研發成本，外包研發成本和風險管理的趨勢日益成長，這正在從根本上改變市場格局。製造商正逐漸拋棄完全依賴內部研發能力的模式，轉而選擇與能夠提高原型製作、測試和檢驗效率的專業合作夥伴攜手。這種策略轉變使原始設備製造商（OEM）能夠將固定成本轉化為變動成本，從而顯著降低研發失敗帶來的財務風險。推動這趨勢的財務壓力十分巨大。德勤2025年3月發布的報告《衡量2024年醫藥創新盈利》指出，藥物研發的平均成本預計將升至22.3億美元，凸顯了嚴重的資金限制，迫使企業透過外部設計支援來分擔成本。

同時，人工智慧和物聯網等先進技術與醫療設備的融合，催生了對超越傳統生命科學專業知識的工程技能的需求。隨著醫療產品向互聯互通、以數據為中心的系統演進，開發人員必須整合複雜的軟體演算法，以提高診斷準確性和病患監測。這種融合需要多學科協作，促使企業與在數位醫療領域擁有豐富經驗的設計合作夥伴攜手合作。這些智慧型系統的快速普及也反映在監管核准的趨勢中。根據 MedTech Dive 2024 年 10 月的一篇報導，截至 2024 年 8 月，美國食品藥物管理局 (FDA) 已核准了950 款搭載人工智慧或機器學習技術的醫療器材。這一發展勢頭正推動著整個行業的成長，MedTech Europe 預計，到 2024 年，歐洲醫療技術市場規模將達到約 1,700 億歐元，這充分展現了技術進步的巨大商業性潛力。

市場挑戰

全球監管環境嚴苛且往往分散，對生命科學產品設計和開發服務市場構成重大阻礙因素。隨著監管機構對安全性和有效性標準日益嚴格，服務供應商必須應對錯綜複雜的合規要求，而這些要求又因地區而異。這種監管摩擦迫使他們將大量資源投入行政檢驗而非核心創新，從而增加開發成本並延長計劃週期。因此，製造商可能會因這些障礙而推遲或放棄產品開發計劃，直接減少訂單開發合作夥伴選擇的計劃數量。

這些監管障礙帶來的財務影響十分嚴重且可衡量。據歐洲醫療技術協會（MedTech Europe）稱，到2024年，根據新的醫療設備法規（MDR）和體外診斷醫療設備法規（IVDR），製造商認證和維護成本將比之前的法規增加高達100%。這些成本的急劇增加迫使企業將資金從新產品設計轉移到合規管理上，從而有效地阻礙了市場發展勢頭，並限制了開發小眾醫療創新產品的財務可行性。

市場趨勢

隨著製造商擁抱循環經濟，採用生態設計原則以實現永續的產品生命週期正在從根本上重塑技術規格。與傳統的線性開發模式不同，這一趨勢強調材料可回收性、模組化拆卸以及在概念階段最大限度地減少有害物質的使用。服務供應商越來越被要求進行生命週期評估 (LCA)，以確保符合歐盟綠色交易等新框架的要求，這需要對組件採購和產品結構進行全面重新評估，以減少對環境的影響。這種策略轉變是可以量化的。根據皇家飛利浦於 2025 年 2 月發布的 2024 年年度報告，專為再利用、再製造和回收而設計的產品所產生的循環收入占公司總銷售額的 24%，這表明永續工程實踐的商業性可行性日益增強。

同時，積層製造技術在客製化醫療植入領域的應用，正推動生產模式從大規模生產轉向以病人為中心的個人化製造。這項技術使設計公司能夠建構促進骨整合的複雜晶格結構，而這是傳統機械加工製程無法實現的。目前，重點正轉向快速的現場生產，使研發合作夥伴能夠以遠低於傳統鑄造工藝的交付前置作業時間，提供高度個人化的整形外科和顱骨解決方案。這種向終端用戶生產的轉變也體現在產業數據中。 2025年3月發表於《3D列印產業》雜誌的一篇報導《Stratasys報告2024會計年度收入下降》指出，該公司2024年製造應用業務的收入佔比成長至36%，顯示其終端設備生產對積層製造技術的依賴程度日益提高。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球生命科學產品設計與開發服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按階段分類（概念和需求開發、設計檢驗、詳細設計和製程開發、製程驗證、製造轉移和設計驗證、生產和商業支援、研究、策略和概念生成）
    • 依應用領域（生物儲存、臨床檢測設備、耗材、診斷設備、手術器械、治療設備）
    • 按最終用途（生物技術公司、受託研究機構、醫療設備製造商、製藥公司）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美生命科學產品設計與開發服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲生命科學產品設計與開發服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區生命科學產品設計與開發服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東與非洲生命科學產品設計與開發服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲生命科學產品設計與開發服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球生命科學產品設計與開發服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Ximedica, LLC
  • DeviceLab Inc.
  • Jabil Inc.
  • Flex Ltd
  • Plexus Corp
  • Nordson Corp
  • Celestica Inc.
  • StarFish Medical Inc.
  • Planet Innovation Pty Ltd
  • Donatelle Plastics, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19134

The Global Life Science Product Design & Development Service Market is projected to expand from USD 25.06 Billion in 2025 to USD 41.61 Billion by 2031, reflecting an 8.82% CAGR. These services encompass the specialized technical processes necessary to conceptualize, engineer, and validate medical devices, pharmaceuticals, and biotechnology innovations for both clinical and commercial applications. Growth is primarily driven by the rising complexity of medical technologies and the strategic need for manufacturers to accelerate time-to-market while controlling operational costs. Consequently, organizations are increasingly turning to external partners for niche engineering expertise to offset the financial risks associated with internal research. Data from the European Federation of Pharmaceutical Industries and Associations indicates that the research-based pharmaceutical industry invested approximately €55,000 million in R&D in Europe in 2024, underscoring the significant capital expenditures driving the demand for efficient development solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 25.06 Billion
Market Size 2031USD 41.61 Billion
CAGR 2026-20318.82%
Fastest Growing SegmentBiological Storage
Largest MarketAsia Pacific

However, market expansion faces a major obstacle in the form of a strict and often inconsistent global regulatory environment. Navigating intricate compliance frameworks, such as the evolving EU Medical Device Regulation and rigorous FDA standards, requires substantial resources and results in extended validation timelines. This regulatory friction creates high barriers to entry and can slow the commercialization of new products, thereby straining the operational capabilities of both development service providers and their clients.

Market Driver

The growing trend of outsourcing to control R&D costs and risks is fundamentally transforming the market as companies adapt to an increasingly expensive development landscape. Manufacturers are moving away from comprehensive internal capability models, opting instead to contract specialized partners who can deliver efficiencies in prototyping, testing, and validation. This strategic shift allows original equipment manufacturers to convert fixed costs into variable costs, significantly lowering financial exposure related to potential development failures. The financial pressure motivating this trend is significant; a March 2025 Deloitte report, 'Measuring the return from pharmaceutical innovation 2024', notes that the average cost to develop a drug has risen to $2.23 billion, highlighting the severe capital strain that necessitates cost-sharing through external design support.

Simultaneously, the integration of advanced technologies such as AI and IoT in medical devices is creating a demand for engineering skills that lie outside traditional life science competencies. As medical products evolve into connected, data-centric systems, developers must incorporate complex software algorithms to improve diagnostic accuracy and patient monitoring. This convergence requires multidisciplinary approaches, prompting companies to engage design partners with established records in digital health. The rapid proliferation of these intelligent systems is reflected in regulatory approval trends; according to an October 2024 MedTech Dive article, the FDA had authorized 950 AI or machine learning-enabled devices as of August 2024. This momentum supports broader industry growth, with MedTech Europe estimating the European medical technology market at roughly €170 billion in 2024, demonstrating the vast commercial scale of these technical advancements.

Market Challenge

The rigorous and frequently fragmented global regulatory landscape serves as a formidable restraint on the Life Science Product Design & Development Service Market. With regulatory bodies enforcing increasingly strict safety and efficacy standards, service providers must navigate a complex web of compliance requirements that vary significantly across regions. This regulatory friction demands that substantial resources be allocated to administrative validation rather than core innovation, thereby inflating development costs and lengthening project schedules. Consequently, manufacturers may delay or cancel product initiatives due to these prohibitive barriers, directly reducing the volume of contracted projects available to development partners.

The financial consequences of these regulatory hurdles are severe and measurable. According to MedTech Europe, in 2024, the costs associated with certification and maintenance for manufacturers under the new Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) rose by up to 100% compared to previous directives. Such drastic cost increases compel companies to redirect capital from new product design toward compliance management, effectively stalling market momentum and limiting the financial viability of developing niche medical innovations.

Market Trends

The implementation of Eco-Design Principles for Sustainable Product Lifecycles is fundamentally reshaping engineering specifications as manufacturers embrace the circular economy. Unlike traditional linear development, this trend emphasizes material recoverability, modular disassembly, and the minimization of hazardous substances during the conceptualization phase. Service providers are increasingly tasked with performing lifecycle assessments (LCA) to ensure compliance with emerging frameworks like the EU Green Deal, necessitating a complete re-evaluation of component sourcing and product architecture to reduce environmental footprints. This strategic pivot is quantifiable; according to Royal Philips' 'Annual Report 2024' released in February 2025, circular revenues-generated from products designed for reuse, refurbishment, and recycling-comprised 24% of the company's total sales, reflecting the growing commercial viability of sustainable engineering protocols.

Concurrently, the adoption of additive manufacturing for customized medical implants is continually shifting production modalities from mass manufacturing to patient-specific fabrication. This technology allows design firms to engineer intricate lattice structures that facilitate osseointegration, a geometry unachievable through conventional subtractive methods. The focus is moving toward rapid point-of-care production, enabling development partners to deliver highly personalized orthopedic and cranial solutions with significantly reduced lead times compared to traditional casting. This transition toward end-use production is evident in industry data; a March 2025 3D Printing Industry article titled 'Stratasys Reports Revenue Decline for FY 2024' noted that Stratasys' manufacturing-focused applications grew to account for 36% of its total revenue in 2024, illustrating the sector's increasing reliance on additive technologies for final device production.

Key Market Players

  • Ximedica, LLC
  • DeviceLab Inc.
  • Jabil Inc.
  • Flex Ltd
  • Plexus Corp
  • Nordson Corp
  • Celestica Inc.
  • StarFish Medical Inc.
  • Planet Innovation Pty Ltd
  • Donatelle Plastics, LLC

Report Scope

In this report, the Global Life Science Product Design & Development Service Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Life Science Product Design & Development Service Market, By Phase

  • Concept & Requirements Development
  • Design Verification
  • Detailed Design & Process Development
  • Process Validation
  • Manufacturing Transfer & Design Validation
  • Production & Commercial Support
  • Research
  • Strategy
  • & Concept Generation

Life Science Product Design & Development Service Market, By Application

  • Biological Storage
  • Clinical Laboratory Equipment
  • Consumables
  • Diagnostic Equipment
  • Surgical Instruments
  • Therapeutic Equipment

Life Science Product Design & Development Service Market, By End Use

  • Biotechnology Companies
  • Contract Research Organizations
  • Medical Device Companies
  • Pharmaceutical Companies

Life Science Product Design & Development Service Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Life Science Product Design & Development Service Market.

Available Customizations:

Global Life Science Product Design & Development Service Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Life Science Product Design & Development Service Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Phase (Concept & Requirements Development, Design Verification, Detailed Design & Process Development, Process Validation, Manufacturing Transfer & Design Validation, Production & Commercial Support, Research, Strategy, & Concept Generation)
    • 5.2.2. By Application (Biological Storage, Clinical Laboratory Equipment, Consumables, Diagnostic Equipment, Surgical Instruments, Therapeutic Equipment)
    • 5.2.3. By End Use (Biotechnology Companies, Contract Research Organizations, Medical Device Companies, Pharmaceutical Companies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Life Science Product Design & Development Service Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Phase
    • 6.2.2. By Application
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Life Science Product Design & Development Service Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Phase
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Life Science Product Design & Development Service Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Phase
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Life Science Product Design & Development Service Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Phase
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Life Science Product Design & Development Service Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Phase
    • 7.2.2. By Application
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Life Science Product Design & Development Service Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Phase
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Life Science Product Design & Development Service Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Phase
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Life Science Product Design & Development Service Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Phase
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Life Science Product Design & Development Service Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Phase
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Life Science Product Design & Development Service Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Phase
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia Pacific Life Science Product Design & Development Service Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Phase
    • 8.2.2. By Application
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Life Science Product Design & Development Service Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Phase
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Life Science Product Design & Development Service Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Phase
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Life Science Product Design & Development Service Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Phase
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Life Science Product Design & Development Service Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Phase
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Life Science Product Design & Development Service Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Phase
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Life Science Product Design & Development Service Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Phase
    • 9.2.2. By Application
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Life Science Product Design & Development Service Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Phase
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Life Science Product Design & Development Service Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Phase
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Life Science Product Design & Development Service Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Phase
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. South America Life Science Product Design & Development Service Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Phase
    • 10.2.2. By Application
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Life Science Product Design & Development Service Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Phase
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Life Science Product Design & Development Service Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Phase
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Life Science Product Design & Development Service Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Phase
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Life Science Product Design & Development Service Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ximedica, LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DeviceLab Inc.
  • 15.3. Jabil Inc.
  • 15.4. Flex Ltd
  • 15.5. Plexus Corp
  • 15.6. Nordson Corp
  • 15.7. Celestica Inc.
  • 15.8. StarFish Medical Inc.
  • 15.9. Planet Innovation Pty Ltd
  • 15.10. Donatelle Plastics, LLC

16. Strategic Recommendations

17. About Us & Disclaimer